D&D Pharmatech, a company specializing in developing new drugs in the glucagon-like peptide (GLP)-1 class, said on the 16th that DD01, its investigational new drug candidate for treating metabolic ...
PharmaTech Expo & LabTech Expo at IPC 2025 are set to be game-changers in advancing India's research landscape. Featuring the latest in advances in instrumentation, it will showcase breakthrough ...
D&D Pharmatech said on the 18th that its U.S. affiliate G-Alpha Therapeutics (G-Alpha) has officially launched. G-Alpha develops alpha radiopharmaceutical therapies. Alpha radiopharmaceutical ...
The Chosun Ilbo on MSN
Eli Lilly awaits key results for Alzheimer's drug Remternutab
U.S. pharmaceutical company Eli Lilly is expected to disclose the top-line results (key findings from phase 3 clinical trials ...
The world's largest bio investment event, the JP Morgan Healthcare Conference (JPMHC), is just a week away. With the total ...
A new study published in Pharmaceutics ( shows that LEON’s FR-JET® modular mixer addresses key manufacturing challenges by ...
Shanghai IVEN Pharmatech Engineering Co. Ltd. has successfully completed a modern intravenous (IV) solution pharmaceutical plant for a US Client in the United States, marking a historic milestone as ...
The KOSPI continued its upward trend for the sixth consecutive trading day, setting a new all-time closing high. On January 9 ...
PharmStars is accepting applications for its Spring 2026 cohort: “Digital Innovations in Operations and Outcomes.” Apply by January 25. BOSTON, MA, UNITED STATES, January 6, 2026 /EINPresswire.com/ — ...
Major Korean biopharmaceutical firms are gearing up to showcase their vision and strengths at the 44th J.P. Morgan Healthcare ...
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback